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As mothers get older and assisted 
conception becomes more common 
in developed countries, the incidence 
of multiple births—primarily of 
nonidentical siblings, but also of identical 
ones—has dramatically increased. 
Multiple pregnancies are high-risk 
pregnancies, with preterm delivery and 
monochorionicity (shared placenta) the 
major problems. Consequently, efforts are 
underway to optimize the management 
of these pregnancies. 
While identical (monozygotic) twins 
are much less common than dizygotic 
ones, monozygotic twinning events are 
increased after induced ovulation and in 
vitro fertilization. Monozygotic twins can 
be diamniotic dichorionic (two amniotic 
sacs, two placentas), monoamniotic 
monochorionic (one amniotic sac, one 
placenta), or diamniotic monochorionic 
(two amniotic sacs, one placenta). The 
last type accounts for approximately two-
thirds of all monozygotic twins. 
Monochorionic twins are at higher 
risk because they share a common 
placenta; they are primarily at risk from 
circulation abnormalities like twin–twin 
transfusion syndrome (the smaller twin 
[donor] does not get enough blood 
while the larger twin [recipient] becomes 
volume overloaded) and intrauterine 
growth restriction. However, the 
majority of diamniotic monochorionic 
twin pregnancies do not develop such 
complications. 
Nicholas Fisk and colleagues 
have studied records of 151 
seemingly uncomplicated diamniotic 
monochorionic pregnancies and found a 
surprisingly high rate of fetal death: ten 
unexpected intrauterine deaths occurred 
in seven of the 151 pregnancies with no 
prior signs of complications. All deaths 
occurred within two weeks of a normal 
scan, at a median gestational age of 34 
weeks and 1 day. 
The authors conclude that “despite 
intensive fetal surveillance, structurally 
normal monochorionic diamniotic 
twin pregnancies without twin–twin 
transfusion syndrome and intrauterine 
growth restriction are complicated by a 
high rate of intrauterine death.” As the 
deaths occurred predominantly after 32 
weeks’ gestation, the authors suggest 
that the prospective risk for fetal death in 
these pregnancies might be eliminated 
by elective preterm delivery after 32 
weeks. 
In an accompanying Perspective (DOI: 
10.1371/journal.pmed.0020180), Jane 
Cleary-Goldman and Mary D’Alton agree 
that, despite the limitations of the study 
(its retrospective nature, small numbers, 
and lack of dichorionic controls), 
it highlights a critical question for 
obstetricians, namely, “when is the ideal 
gestational age to deliver apparently 
uncomplicated monochorionic twins?” 
As Cleary-Goldman and D’Alton discuss, 
at 32 weeks of gestation many of the 
risks associated with prematurity have 
abated, but the remaining ones are 
not negligible. Until larger prospective 
observational studies have been 
conducted, balancing these risks remains 
challenging. 
Barigye O, Pasquini L, Galea P, Chambers 
H, Chappell L, et al. (2005) High 
risk of unexpected late fetal death in 
monochorionic twins despite intensive 
ultrasound surveillance: A cohort study. 
DOI: 10.1371/journal.pmed.0020172
Assessing the Risks of Twin Pregnancies
DOI: 10.1371/journal.pmed.0020195
Smoking is the single largest preventable cause of disease and 
premature death, according to the World Health Organization. 
Smoking-related diseases kill one in ten adults globally, i.e., 4 
million deaths annually; by 2030, if current trends continue, 
smoking will kill one in six people. Smoking is a prime factor 
in heart disease, stroke, and chronic lung disease, which 
cost the United States more than $150 billion a year. The 
relationship between smoking and cardiovascular disease is well 
documented, as is the association of smoking with increased 
levels of inﬂ  ammatory markers and accelerated atherosclerosis. It 
is also well known that when smokers quit, their risk of mortality 
and future cardiac events declines, but there is little data 
quantifying the rate of this risk reduction.
Smoking triggers an immunologic response to vascular 
injury, which is associated with increased levels of inﬂ  ammatory 
markers, such as C-reactive protein and white blood cell count. 
Several studies have shown that such markers predict future 
cardiovascular events. Markers such as C-reactive protein are also 
increasingly implicated in the pathogenesis of atherosclerosis. 
There are, however, still some gaps in our knowledge of 
cardiovascular disease, smoking, and the predictive use of such 
markers. For example, few studies have examined the impact 
of smoking cessation on levels of inﬂ  ammatory markers or on 
cardiovascular risk reduction; the level and rate at which the 
inﬂ  ammatory response subsides following smoking cessation 
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If you are overweight, then losing weight is good for your 
health, surely? Unfortunately, the evidence on which an answer 
to this seemingly simple question might be based is at best 
equivocal, and at worst very controversial. Previous work has 
shown that weight loss in obese people improves risk factors 
associated with cardiovascular diseases and diabetes, but 
studies are conﬂ  icting on the long-term effects of weight loss on 
mortality. A study in this month’s PLoS Medicine by Jaakko Kaprio 
and colleagues on a Finnish dataset adds more evidence to this 
debate, but experts are divided on what can be concluded from it.
The major difﬁ  culty in getting clear results on this question 
is that it is virtually impossible to do a controlled trial to 
answer it. Hence, the evidence accumulated has come mostly 
from epidemiological studies, but it is notoriously difﬁ  cult to 
remove all confounding factors from these studies. Kaprio and 
colleagues’ study is another epidemiological study, but we 
should not simply dismiss the data as unreliable just because 
of the problems inherent to such a study design. Instead, we 
should consider their study in the light of all the other evidence 
available.
Starting from a group of 19,993 twins from Finland who 
have been studied since 1975, the authors gathered data from 
the 2,957 overweight participants who remained after they 
had excluded people with pre-existing disease, and those 
with missing data. These twins had been asked in 1975 if they 
intended to lose weight, and then had information on weight 
collected in 1981. Information on mortality was then collected 
over the next 18 years; the authors then analyzed mortality in 
relation to intention to lose weight and actual weight change. 
In total, 268 people died. When the results were analyzed, the 
surprising ﬁ  nding was that people who intended to lose weight, 
and who did so, had a somewhat higher mortality than those 
who intended to lose weight but whose weight remained stable, 
or went up. People who intended to lose weight, and who did 
so, also had a slightly higher mortality than those who did not 
intend to lose weight and whose weight was stable.
The problems with such a study are outlined in an 
accompanying Perspective (DOI: 10.1371/journal.pmed.002018) 
by Meir Stampfer from Harvard School of Public Health, and 
there is no doubt that these results seem counterintuitive. 
Some readers may take away the idea from this paper that 
overweight people should not be advised to lose weight, but 
Stampfer cautions against that interpretation. Perhaps the safest 
interpretation of these results is that by the time adults are 
overweight, the health beneﬁ  ts of losing weight are not clear-cut. 
If there is one message therefore that should be taken from the 
paper it is this: in order to prevent the associated health effects 
of obesity, preventing obesity, especially in childhood, should be 
an overriding public health priority.
The study leaves us with the question of how intentional 
weight loss could lead to excess mortality. The authors suggest 
that this could be due to the unavoidable loss of lean body mass, 
which according to several other studies may increase mortality, 
and which may outweigh the beneﬁ  cial effects of losing fat 
mass in healthy individuals. The authors therefore conclude that 
“the long-term effects of weight loss are complex, and they may 
be composed of oppositely operating effects with net results 
reﬂ  ecting the balance between these effects.”
Sørensen TIA, Rissanen A, Korkeila M, Kaprio J (2005) Intention 
to lose weight, weight changes, and 18-y mortality in overweight 
individuals without co-morbidities. DOI: 10.1371/journal.
pmed.0020171
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is also uncertain. Furthermore, whether traditional risk factors 
can explain the decline in cardiovascular risk following smoking 
cessation is also unclear.
In this month’s PLoS Medicine, Arvind Bakhru and Thomas 
Erlinger investigate the association between smoking and 
smoking cessation and levels of inﬂ  ammatory markers and 
cardiovascular risk factors. Data were gathered on 15,489 US 
adults between 1988 and 1994 in the Third National Health and 
Nutrition Examination Survey. Of these, 7,665 were classiﬁ  ed 
as never smokers, 3,459 were former smokers, and 4,365 were 
current smokers.
The investigators focused on changes in C-reactive 
protein, white blood cell count, albumin, and ﬁ  brinogen, and 
the traditional risk factors—total cholesterol, high-density 
lipoprotein cholesterol, triglycerides, systolic blood pressure, 
and diabetes—that occurred with decreased smoking intensity 
and increased time since smoking cessation. They found that 
inﬂ  ammatory markers had a dose-dependent and temporal 
relationship to smoking and smoking cessation. They noted 
that both inﬂ  ammatory and traditional risk factors improved 
with less smoking, but as the time since smokers quit increased, 
inﬂ  ammatory markers resolved more slowly than traditional 
cardiovascular risk factors. Still, the smoking-associated 
inﬂ  ammatory response returned to normal within ﬁ  ve years after 
smokers quit, suggesting that the vascular effects were reversible 
and that cardiovascular risk subsides gradually with reduced 
exposure.
The authors conclude that these ﬁ  ndings support the 
hypothesis that cardiovascular risk falls as inﬂ  ammatory 
response falls, and that inﬂ  ammatory markers are good 
indicators of this risk reduction. Despite limitations of the study, 
including possible errors from self-reporting and lack of data on 
second-hand smoke and newer measures such as interleukin-6 
and high-sensitivity C-reactive protein, the inﬂ  ammatory markers 
studied here demonstrated a much clearer trend and longer-
lasting effect after smoking cessation than traditional risk factors, 
and hence were more useful and accurate markers of disease. 
As with related studies, these results suggest that smoking 
cessation should be a more prominent goal of public policy, and 
the authors conclude that policymakers must pursue smoking 
cessation plans as an opportunity to make savings on health care 
through cardiovascular risk reduction. Further research should 
explore the acute phase response in the months after smoking 
cessation, which this and other studies have not been able to 
study adequately.
Bakhru A, Erlinger TP (2005) Smoking cessation and cardiovascular 
disease risk factors: Results from the Third National Health and 
Nutrition Examination survey. DOI: 10.1371/journal.pmed.0020160
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Lassa fever, a viral hemorrhagic fever 
caused by the Lassa virus and commonly 
transmitted by its rodent host, is endemic 
in certain areas of West Africa, where 
several hundred thousand people are 
estimated to be infected each year. 
The disease is asymptomatic or mild in 
approximately 80% of infected patients, 
but the remaining 20% have severe 
multisystem disease. Estimated overall 
mortality is 1%–2%. 
Death rates are particularly high 
for women in the third trimester of 
pregnancy, and for fetuses, about 95% 
of which die in the uterus of infected 
pregnant mothers. The most common 
complication of Lassa fever is deafness. 
Various degrees of deafness occur in 
approximately one-third of cases, and in 
many cases hearing loss is permanent. 
Disease severity does not seem to affect 
this complication: deafness may develop 
in mild as well as in severe cases. 
Lassa fever remains a serious 
challenge to public health in West Africa, 
threatening both local residents in 
rural areas and those who serve them, 
particularly medical care providers. 
Ribavirin, an antiviral drug, has been 
used successfully in Lassa fever patients, 
but it needs to be given early and is not 
readily available in the infected areas. 
Given the ecology of the rodent host and 
conditions in the endemic area, a vaccine 
is mandatory for control. Lassa vaccine 
initiatives have suffered from a lack of 
funding in the past, but bioterrorism and 
recent importation of the disease to the 
United States and Europe have brought 
new resources to Lassa virus science.
Early attempts to develop a Lassa 
fever vaccine in the 1980s focused 
on killed pathogens, which caused a 
strong humoral response but failed 
to protect nonhuman primate test 
animals. Subsequently, recombinant 
vaccines used vaccinia vectors carrying 
different combinations of structural Lassa 
proteins. Some of these protected 90% 
of nonhuman primates from a lethal 
challenge in the absence of a strong 
humoral response, suggesting that cellular 
responses are important for protection. 
Use of vaccinia vectors in humans is 
problematic, especially in areas where 
HIV infection is common—immune-
suppressed individuals can develop 
serious skin lesions—and several 
alternative vaccines based on other 
vectors as well as harmless vaccinia 
ones are under development. Thomas 
Geisbert and colleagues now report 
promising results with a replication-
competent vaccine based on attenuated 
recombinant vesicular stomatitis virus 
vectors expressing the Lassa viral 
glycoprotein. A single intramuscular 
vaccination protected all four vaccinated 
cynomolgus macaques against a 
lethal challenge of a particular Lassa 
strain, while two control monkeys that 
had received empty vector died after 
injection with the same dose of virus. 
These are encouraging results, 
but future larger studies will need 
to assess the duration of protection 
and demonstrate the safety of this 
replication-competent vaccine. 
Another crucial question is how quickly 
vaccinated individuals acquire protection, 
and thus whether the vaccine would be 
suitable for creating a ring of vaccination 
around an outbreak zone, the most 
likely early application of a promising 
candidate vaccine. In addition, there are 
at least four different strains of the Lassa 
virus, and an ideal vaccine should provide 
protection across all strains. Finally, 
conducting trials in endemic areas, many 
of which lack political stability, remains a 
serious challenge.
Geisbert TW, Jones S, Fritz EA, Shurtleff 
AC, Geisbert JB, et al. (2005) Development 
of a new vaccine for the prevention of Lassa 
fever. DOI: 10.1371/journal.pmed.0020183
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Exposure to short periods of very loud noise can cause 
tinnitus—a persistent ringing or buzzing in the ears that 
cannot be blocked out. Tinnitus may affect around 10%–15% 
of the population; severe tinnitus is very debilitating (1%–2% 
of the population). Previous work has shown that tinnitus has a 
neurophysiological basis, but precisely which parts of the brain 
and the auditory circuits are involved is not yet understood.
The human ear is essentially a very sensitive vibration sensor, 
one that is able to receive the minute longitudinal vibrations in air 
that make up sound waves. It can detect sounds from 20 Hertz (Hz) 
(very low pitch) to 20,000 Hz (very high pitch) but is particularly 
sensitive to sounds in the range of 500–5,000 Hz—the so-called 
speech frequencies. However, the ear, and in particular the cochlea, 
or inner ear, can be damaged by exposure to excess noise, leading 
to permanent damage to the ear, i.e., deafness. 
Some studies in both animals and humans have suggested 
that tinnitus and hearing loss may be related. These studies have 
found that neurons in regions of the auditory cortex that have 
been deprived of stimuli because of hearing loss change their 
receptive ﬁ  eld and may develop enhanced spontaneous activity. 
Other studies, such as some involving neuroimaging using 
positron emission tomography, have suggested that parts of the 
brain involved in attention and emotional regulation might be 
involved in the production of tinnitus. 
One of the key research targets in tinnitus has been 
investigation of cortical activity, especially in animal models 
of tinnitus, but studies in humans have been rare. Previous 
studies have identiﬁ  ed temporal and frontal temporal changes 
in individuals whose tinnitus is severely disabling; however, 
there have been no group studies comparing abnormalities 
of ongoing, spontaneous neuronal activity in people with and 
without tinnitus.
In this month’s PLoS Medicine, Nathan Weisz and colleagues 
studied 17 patients with chronic tinnitus and hearing loss and 16 
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Color-enhanced transmission electron 
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As cells specialize during development 
they pass through different levels of 
differentiation, from the earliest stem 
cells through to the highly specialized 
types that make up the body’s organs. 
Hence, a number of different tissues 
may derive from common precursors. 
For example, muscle, fat, cartilage, 
and bone are all derived from a group 
of mesenchymal precursor cells that 
originate in the paraxial mesoderm. So 
pluripotent (i.e., able to differentiate into 
any cell type) human embryonic stems 
cells are potentially a starting point for 
the regeneration of all types of diseased 
or damaged organs (and already 
researchers have shown that it is possible 
to stimulate human embryonic stem cells 
to differentiate into speciﬁ  c cell types 
such as neural or hematopoietic cells). 
The isolation of intermediate multipotent 
stem cells (which can differentiate into 
a limited number of cell types) may also 
be valuable. For example, the production 
of an unlimited supply of mesenchymal 
precursors would be very useful, not 
only for the understanding of how 
cells differentiate, but also for eventual 
practical application.
In this month’s PLoS Medicine, Lorenz 
Studer and colleagues from the Sloan-
Kettering Institute in New York describe 
a protocol for deriving mesenchymal 
precursors, which they then show are 
capable of differentiating into specialized 
cell types. 
They used two undifferentiated stem 
cell lines—from the 22 lines that were 
approved in 2001 by President Bush 
for use in federally funded research in 
the United States. The speciﬁ  cations for 
approval for these lines are clear—see 
the guidelines at http://stemcells.nih.
gov/research/registry/eligibilityCriteria.
asp. The number of human embryonic 
stem cell lines available for researchers 
are strictly limited, making it necessary to 
develop protocols that expand these cells 
along various lineages. 
In order to differentiate the cells into 
mesenchymal precursors, the stem cell 
lines were cocultured with mouse feeder 
cells to produce ﬁ  ve different polyclonal 
lines. The authors then cultured these 
polyclonal precursors with appropriate 
tissue-speciﬁ  c stimulation in attempt 
to produce fat, bone, cartilage, or 
muscle cells. The evidence that the 
authors provide for these cells being 
differentiated includes analysis of 
gene expression, surface antigens, and 
immunocytochemistry typical of the 
mature tissues. For example, the authors 
were able to show the presence of fat 
granules in adipocytes, calcium in the 
matrix of osteogenic cells, and collagen 
in chondrocytes. It was harder to produce 
muscle cells, but even these types of cells 
could eventually be induced by speciﬁ  c 
culture conditions.
What are the possible concerns 
about these types of studies? One 
obvious one is the potential for 
residual undifferentiated cells to turn 
into tumors, but the authors tested 
the differentiated cell cultures for 
cell surface markers characteristic of 
undifferentiated cells and found no 
evidence of them. Another worry for 
Turning Stem Cells into Mesenchymal Tissues
DOI: 10.1371/journal.pmed.0020201
DOI: 10.1371/journal.pmed.0020201.g001
Myotubes formed in vitro from human 
ES–derived mesenchymal precursors upon 
cocultures with C2C12 myoblasts 
control individuals with normal hearing. Patients were asked to 
ﬁ  ll in a questionnaire about the impact of tinnitus on their lives 
and had their levels of tinnitus assessed.
The team’s methods differed from previous work in that the 
team chose to examine the power spectrum of neuromagnetic 
oscillatory activity during rest, whereas previous studies had 
focused on measuring neurophysiological responses following 
sounds.
Normally in awake and healthy subjects a certain rhythm 
of brain activity at 8–12 Hz—the so-called alpha rhythm—is 
dominant. Finding enhanced slow-wave, or delta, activity 
(<4 Hz) in awake subjects is usually a sign of a dysfunctional 
neuronal network, as these waves can be observed in various 
neurological and psychiatric disorders. Weisz and colleagues’ 
analysis of the frequency spectrum of recorded magnetic 
ﬁ  elds revealed that the energy in the alpha band was strongly 
reduced and that of the delta band enhanced in the group with 
tinnitus compared with the individuals with normal hearing. 
This pattern was particularly pronounced in the temporal 
regions, and overall the effects were stronger for the alpha than 
for the delta frequency band.
This is the ﬁ  rst study to show these changes in delta and 
alpha spontaneous cortical activity, say the authors. But they 
concede it is still unclear whether the enhancement of delta 
activity compared with alpha is the abnormal activity perceived 
as tinnitus. However, the fact that regions that show slow-wave 
activity during slow-wave sleep are also regions of low alpha 
activity supports the idea that changes in cortical activity might 
be mediated by sensory deprivation, in this case that partial 
hearing loss might be involved in producing tinnitus. 
Tinnitus-related distress as assessed by the questionnaire was 
strongly associated with this abnormal spontaneous activity, 
especially in the right temporal and left frontal areas, thus 
pinpointing a possible tinnitus-related cortical network. 
A limitation of this study was that the tinnitus group also had 
high-frequency hearing loss, whereas the control group did not; 
the ideal control group would have been patients with the same 
sort of hearing loss but no tinnitus.
In discussing their ﬁ  ndings, the authors suggest that their 
study supports previous work indicating that the prefrontal 
cortex is a candidate region for integration of the sensory and 
emotional aspects of tinnitus. Further studies should focus on 
frontal areas, which could allow identiﬁ  cation of interactions and 
modulating inﬂ  uences that higher-order psychological processes 
(e.g., emotions and thoughts) may have on the generation of 
tinnitus in the auditory cortex. 
Weisz N, Moratti S, Meinzer M, Dohrmann K, Elbert T (2005) 
Tinnitus perception and distress is related to abnormal spontaneous 
brain activity as measured by magnetoencephalography. DOI: 
10.1371/journal.pmed.0020153
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the use of these cells directly in humans 
is the need, at least at the beginning, 
to culture the cells with mouse feeder 
cells—obviously no human treatment 
could contain cells contaminated with 
mouse cells. Further development of 
protocols will be needed to address 
this issue. However, as the authors 
comment, “the high purity, unlimited 
availability, and multipotentiality of 
hESMPCs [human embryonic stem 
cell–derived mesenchymal precursor 
cells] will provide the basis for future 
therapeutic efforts using these cells in 
preclinical animal models of disease.” 
In addition, the techniques described 
here will provide a very useful resource 
for studying mesenchymal cell 
development.
Barberi T, Willis LM, Socci ND, Studer 
L (2005) Derivation of multipotent 
mesenchymal precursors from human 
embryonic stem cells. DOI: 10.1371/journal.
pmed.0020161
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